Rosenbaum David P. 4
4 · ARDELYX, INC. · Filed Jun 5, 2024
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Rosenbaum David P.
SVP, Drug Development
Transactions
- Sale
Common Stock
2024-06-03$7.00/sh−17,872$125,104→ 158,502 total(indirect: By Spouse)
Holdings
- 77,592(indirect: By Trust)
Common Stock
- 376,479
Common Stock
Footnotes (2)
- [F1]The shares are directly held by the Reporting Person's wife.
- [F2]The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.